SEC Form 4 reporting owner

Louie Ngar Yee

Louie Ngar Yee has filed 4 Form 4 transactions reported between December 22, 2025 and June 30, 2026, as Director of MAIA Biotechnology, Inc..

Name as filed: Louie Ngar Yee

Open-market buys, 24 mo

$100K

1 lines

Open-market sales, 24 mo

None

reported

Companies

with Form 4 filings

Latest transaction

Jun 30, 2026

transaction date

Roles and reported holdings

MAIAMAIA Biotechnology, Inc.
Dec 22, 2025 – Jun 30, 2026
Director
Held directly1,248,888 sh as of Dec 22, 2025 · Form 4
24 months: $100K bought

Transaction history

All 4 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

Date	Company	Type	Shares	Price	Value	Owned after	Filing
Jun 30, 2026	MAIADirector	Grant or awardCode A · direct	32,630	—	—	32,630	Form 4
Mar 31, 2026	MAIADirector	Grant or awardCode A · direct	33,748	—	—	33,748	Form 4
Dec 31, 2025	MAIADirector	Grant or awardCode A · direct	29,789	—	—	29,789	Form 4
Dec 22, 2025	MAIADirector	Open-market purchaseCode P · direct	81,699	$1.22	$100K@ $1.22	1,248,888	Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.